The Beck Depression Inventory II

1763 Words8 Pages
The Beck Depression Inventory-II was developed by Aaron T. Beck, Gregory K. Brown, and Robert A. Steer. The inventory was published by The Psychological Corporation in San Antonio, Texas in 1996. The BDI-II is available on the Q-global which offers 24 hours 7 days a week web-based access (pearsonclinical.com). The Q-global is portable, accessible on mobile devices such as a laptop or tablet (pearsonclinical.com). According to Pearson Clinical, the cost of the BDI-II Q-global starter kit is $84.25 which includes the BDI-II print manual, digital manual and 5 Q-global interpretive reports (pearsonclinical.com). The cost of BDI-II manual (digital) is $54.80. The BDI-II Q-global interpretive report cost $3.05…show more content…
According to Smarr (2003), the instrument was validated using college students, adult and adolescent psychiatric outpatients (Smarr, 2003). Today, the BDI-II is widely used for those patients as well as normal populations. According to Wang & Gorenstein (2013), the BDI-II can be easily adapted in most clinical settings for detecting major depression and recommending a suitable intervention (Wang & Gorenstein, 2013). Thus, in health care settings the BDI-II has been BDI-II has been expanding in practice in the pathologically ill to assess depressive states that occur at high prevalence (Wang & Gorenstein, 2013). The purpose of the BDI-II is to use to measure the severity of depression in adolescents and adults 13 years of age or older. It was established to address the DSM-IV criteria for depression (DSM-IV; American Psychiatric Association, 1994). It is not a diagnostic instrument and the manual cautions the user against using for that purpose (Beck et al., 1961). The latent structure of the BDI-II instrument is described by the somatic and cognitive-affective dimension (Wang & Gorenstein, 2013). Cognitive and non-cognitive are two of the subscales of the BYI-II (Drummond et al., 2016). The content of the BDI-II was grounded on clinical observations and patient description and measures cognitive, affective, somatic, and vegetative
Get Access